Upgrade to SI Premium - Free Trial

Lexaria Bioscience (LEXX)

10.32 +1.28 (14.16%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26 *Est.)

Latest Headlines

Form 8-K Lexaria Bioscience Corp. For: Aug 17 August 17, 2026 12:38 PM - SEC Filing Lexaria signs material transfer agreement with PegBio for GLP-1 study August 13, 2026 9:02 AM - StreetInsider Lexaria Enters a Material Transfer Agreement With PegBio August 13, 2026 9:01 AM - StreetInsider Form 8-K Lexaria Bioscience Corp. For: Aug 04 August 10, 2026 5:00 PM - SEC Filing Form 8-K Lexaria Bioscience Corp. For: Jul 29 July 30, 2026 12:03 PM - SEC Filing Lexaria Bioscience sets 1-for-15 reverse stock split for Aug. 3 July 30, 2026 11:00 AM - StreetInsider Lexaria Announces Effective Date for Reverse Stock Split July 30, 2026 11:00 AM - StreetInsider Form 10-Q Lexaria Bioscience Corp. For: May 31 July 13, 2026 4:23 PM - SEC Filing Lexaria reports partner meetings at BIO convention in San Diego July 6, 2026 9:11 AM - StreetInsider Lexaria Updates Business Development July 6, 2026 9:10 AM - StreetInsider Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule June 25, 2026 9:10 AM - StreetInsider Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule June 23, 2026 9:25 AM - StreetInsider GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand June 17, 2026 9:26 AM - StreetInsider Lexaria begins animal study on next-generation GLP-1 drugs June 9, 2026 9:25 AM - StreetInsider Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway June 9, 2026 9:25 AM - StreetInsider Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program June 3, 2026 9:25 AM - StreetInsider Full Article List